Trulieve Cannabis Corp. (TRUL.CN)
CAD 7.15
(1.85%)
CAD 7.15
(1.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -21.97 Million USD | 25.15% |
| 2022 | 239.75 Million USD | -18.77% |
| 2021 | 283.58 Million USD | 35.5% |
| 2020 | 207.87 Million USD | -31.28% |
| 2019 | 128.53 Million USD | 292.74% |
| 2018 | 38.25 Million CAD | 211959.59% |
| 2017 | 10.47 Million CAD | -396.25% |
| 2016 | -4 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 97.34 Million USD | 6.27% |
| 2024 Q1 | 89.08 Million USD | 22.81% |
| 2023 Q3 | 77.34 Million USD | 62.49% |
| 2023 Q4 | 69.14 Million USD | -10.6% |
| 2023 Q1 | 53.1 Million USD | 138.12% |
| 2023 Q2 | 47.6 Million USD | -10.36% |
| 2023 FY | - USD | 25.15% |
| 2022 Q2 | 91.58 Million USD | 6.2% |
| 2022 Q4 | 22.3 Million USD | -69.41% |
| 2022 FY | - USD | -18.77% |
| 2022 Q1 | 86.24 Million USD | 266.19% |
| 2022 Q3 | 72.9 Million USD | -20.4% |
| 2021 Q4 | 23.55 Million USD | -70.96% |
| 2021 Q3 | 81.1 Million USD | -8.51% |
| 2021 Q2 | 88.65 Million USD | 6.56% |
| 2021 Q1 | 83.2 Million USD | -3.52% |
| 2021 FY | - USD | 35.5% |
| 2020 Q1 | 42.08 Million USD | -49.62% |
| 2020 Q4 | 86.23 Million USD | 114.67% |
| 2020 Q3 | 40.17 Million USD | 2.0% |
| 2020 FY | - USD | -31.28% |
| 2020 Q2 | 39.38 Million USD | -6.42% |
| 2019 Q4 | 83.52 Million USD | -15.68% |
| 2019 Q1 | 29.16 Million USD | 21.22% |
| 2019 FY | - USD | 292.74% |
| 2019 Q2 | 90.72 Million USD | 211.12% |
| 2019 Q3 | 99.06 Million USD | 9.19% |
| 2018 Q1 | -30.78 Thousand USD | -154.43% |
| 2018 Q3 | 26.32 Million USD | 53154.63% |
| 2018 FY | - CAD | 211959.59% |
| 2018 Q4 | 24.05 Million USD | -8.63% |
| 2018 Q2 | -49.62 Thousand USD | -61.2% |
| 2017 FY | - CAD | -396.25% |
| 2017 Q2 | -11.38 Thousand USD | -1191.95% |
| 2017 Q4 | -12.09 Thousand USD | 9.92% |
| 2017 Q3 | -13.43 Thousand USD | -17.94% |
| 2017 Q1 | 1043.06 USD | 102.28% |
| 2016 Q4 | -45.68 Thousand USD | -45.11% |
| 2016 Q3 | -31.48 Thousand USD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | -261.855% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -993.165% |
| Blueberries Medical Corp. | -1.22 Million CAD | -1698.838% |
| The BC Bud Corporation | -1.19 Million CAD | -1737.604% |
| BioNxt Solutions Inc. | -6.48 Million CAD | -238.925% |
| CordovaCann Corp. | -1.6 Million CAD | -1271.381% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -737.751% |
| Captor Capital Corp. | 2.42 Million CAD | 1007.743% |
| City View Green Holdings Inc. | -2.01 Million CAD | -991.011% |
| 1CM Inc. | 1.31 Million CAD | 1773.206% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -88545.989% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -895.203% |
| IM Cannabis Corp. | -2.79 Million CAD | -687.742% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -399.24% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -5503.545% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -588.318% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 2025.191% |
| Ovation Science Inc. | -778.83 Thousand CAD | -2721.918% |
| Pharmadrug Inc. | -1.33 Million CAD | -1546.276% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | -262.908% |
| RAMM Pharma Corp. | -6.3 Million CAD | -248.742% |
| RIV Capital Inc. | -20.28 Million CAD | -8.371% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | -292.815% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 71.675% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -644.836% |
| 1933 Industries Inc. | -10.03 Million CAD | -119.058% |
| Red Light Holland Corp. | -5.25 Million CAD | -318.162% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -2761.745% |
| Xebra Brands Ltd. | -1.49 Million CAD | -1370.104% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -1457.327% |